ABVX's edge: mechanism uncertainty created opportunity
The bull case made for Abivax (ABVX) was that the market's focus on the drug's unclear mechanism of action created a mispricing, overshadowing strong efficacy signals.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.